[go: up one dir, main page]

AR005008A1 - Compuestos benzotiazolona etanaminas, procedimiento e intermediarios para su preparacion y su uso en la preparacion de medicamentos - Google Patents

Compuestos benzotiazolona etanaminas, procedimiento e intermediarios para su preparacion y su uso en la preparacion de medicamentos

Info

Publication number
AR005008A1
AR005008A1 ARP960105568A ARP960105568A AR005008A1 AR 005008 A1 AR005008 A1 AR 005008A1 AR P960105568 A ARP960105568 A AR P960105568A AR P960105568 A ARP960105568 A AR P960105568A AR 005008 A1 AR005008 A1 AR 005008A1
Authority
AR
Argentina
Prior art keywords
preparation
compounds
benzotiazolone
intermediaries
medicines
Prior art date
Application number
ARP960105568A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR005008A1 publication Critical patent/AR005008A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Compuestos de formula (I), donde X representa naftilo opcionalmente substituido con alquilo o con halogeno; y p, q y r representanindependientemente 2 o 3, y sales de los mismos farmaceuticamente aceptables; procedimientos para supreparaci on y metodos para su uso. Los compuestos sonagonistas receptores de dopamina DA2 y agonistas adrenoreceptores de Beta2.
ARP960105568A 1995-12-23 1996-12-09 Compuestos benzotiazolona etanaminas, procedimiento e intermediarios para su preparacion y su uso en la preparacion de medicamentos AR005008A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9526511.2A GB9526511D0 (en) 1995-12-23 1995-12-23 Pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
AR005008A1 true AR005008A1 (es) 1999-04-07

Family

ID=10786064

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960105568A AR005008A1 (es) 1995-12-23 1996-12-09 Compuestos benzotiazolona etanaminas, procedimiento e intermediarios para su preparacion y su uso en la preparacion de medicamentos

Country Status (27)

Country Link
US (1) US5929100A (es)
EP (1) EP0918760B1 (es)
JP (1) JP2000502681A (es)
KR (1) KR19990076688A (es)
CN (1) CN1072214C (es)
AR (1) AR005008A1 (es)
AT (1) ATE209638T1 (es)
AU (1) AU704506B2 (es)
BR (1) BR9612234A (es)
CA (1) CA2238877A1 (es)
CZ (1) CZ288704B6 (es)
DE (1) DE69617472D1 (es)
EE (1) EE03440B1 (es)
GB (1) GB9526511D0 (es)
HU (1) HUP9900100A3 (es)
IL (2) IL142502A0 (es)
IS (1) IS4759A (es)
MX (1) MX9804828A (es)
NO (1) NO982927L (es)
NZ (1) NZ325500A (es)
PL (1) PL327475A1 (es)
RU (1) RU2177476C2 (es)
SK (1) SK82098A3 (es)
TR (1) TR199801196T2 (es)
TW (1) TW401411B (es)
WO (1) WO1997023470A1 (es)
ZA (1) ZA9610354B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009018A1 (en) * 1997-08-14 1999-02-25 Kirin Beer Kabushiki Kaisha BENZOTHIAZOLONE DERIVATIVES HAVING SELECTIVE β2 RECEPTOR AGONIST ACTIVITY
PE20050130A1 (es) * 2002-08-09 2005-03-29 Novartis Ag Compuestos organicos
GB0218629D0 (en) * 2002-08-09 2002-09-18 Novartis Ag Organic compounds
CA2543858C (en) 2003-11-21 2014-04-15 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200738659A (en) * 2005-08-29 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
KR20110017456A (ko) 2008-06-18 2011-02-21 아스트라제네카 아베 호흡기 장애의 치료를 위한 베타2-아드레날린성 수용체 효능제로서 작용하는 벤족사지논 유도체

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
DK514585A (da) * 1984-11-08 1986-05-09 Syntex Inc Aminoethylanilinderivater
DE3728695A1 (de) * 1987-08-25 1989-03-09 Schering Ag Neue benzimidazol-derivate
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds
US5648370A (en) * 1990-11-20 1997-07-15 Astra Pharmaceuticals Limited 7-(2-aminoethyl) benzothiazolones
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds

Also Published As

Publication number Publication date
CZ168498A3 (cs) 1998-09-16
MX9804828A (es) 1998-09-30
EE03440B1 (et) 2001-06-15
HUP9900100A2 (hu) 1999-05-28
NZ325500A (en) 1999-01-28
EP0918760A1 (en) 1999-06-02
BR9612234A (pt) 1999-07-13
KR19990076688A (ko) 1999-10-15
NO982927D0 (no) 1998-06-23
US5929100A (en) 1999-07-27
AU704506B2 (en) 1999-04-22
AU1402597A (en) 1997-07-17
EE9800193A (et) 1998-12-15
ATE209638T1 (de) 2001-12-15
SK82098A3 (en) 1998-11-04
PL327475A1 (en) 1998-12-07
IS4759A (is) 1998-05-27
NO982927L (no) 1998-06-23
WO1997023470A1 (en) 1997-07-03
HUP9900100A3 (en) 2001-10-29
DE69617472D1 (de) 2002-01-10
TW401411B (en) 2000-08-11
CN1211242A (zh) 1999-03-17
ZA9610354B (en) 1997-06-23
CZ288704B6 (cs) 2001-08-15
IL142502A0 (en) 2002-03-10
TR199801196T2 (xx) 1998-10-21
EP0918760B1 (en) 2001-11-28
IL124998A0 (en) 1999-01-26
RU2177476C2 (ru) 2001-12-27
CA2238877A1 (en) 1997-07-03
GB9526511D0 (en) 1996-02-28
JP2000502681A (ja) 2000-03-07
CN1072214C (zh) 2001-10-03

Similar Documents

Publication Publication Date Title
DK0591280T3 (da) Anvendelse af tetrahydrocarbazolderivater som 5HT1-receptoragonister
ES2076688T3 (es) Derivados de 2-hidroxi-2-feniletilamina utiles como agonistas de beta-3-adrenoceptores.
NO943762L (no) Indolderivater som 5-HT 1 agonister
MX9301986A (es) Derivados de perhidroisoindol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9504332A (es) Derivados de amino(tio)eter y procedimiento para su preparacion.
ES533821A0 (es) Procedimiento para preparar n2-acil-9-(1, 3-dihidroxi-2-propoximetil)-guaninas y sus sales farmaceuticamente aceptables
FI970310A0 (fi) 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
NO902933D0 (no) Fremgangsmaate for fremstilling av 2-(aminoaryl)indoler ogindoliner samt anvendelse som medikamenter.
ES510348A0 (es) "procedimiento de preparacion de nuevos derivados 3,4-dihidro-5h-2,3-benzodiazepinos y de sus sales de adicion acidas farmaceuticamente aceptables".
FI922806A0 (fi) Substituerade 4-fenyl-4 -piperidinkarboxamider med baode lokalbedoevande och smaertstillande effekt samt foerfaranden foer deras framstaellning.
FI962969A7 (fi) Indolijohdannaisia 5-HT1:n agonisteina
AR005008A1 (es) Compuestos benzotiazolona etanaminas, procedimiento e intermediarios para su preparacion y su uso en la preparacion de medicamentos
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
NO954287L (no) Anvendelse av indolderivater som 5-HT1 agonister
DK0387821T3 (da) 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
MX9204635A (es) Procedimiento para la preparacion de derivados de beta-fenilisoserina.
MX9604765A (es) Derivados de 5-heterociclico 1,5-benzodiazepinas que modulan la cck o gastrina.
FI944727L (fi) Indolijohdannaisia 5-HT1:n kaltaisina agonisteina
ES511097A0 (es) "procedimiento para la preparacion de derivados de oxindol".
ES513618A0 (es) "procedimiento para la preparacion de derivados de 2-hidroxi-3-azolilpropano".
ES2039211T3 (es) Nuevos n-glicosilamidoderivados, procedimientos para su obtencion y su empleo como medicamentos.
DK0427827T3 (da) 8alfa-acylaminoergoliner, deres fremstilling og anvendelse som lægemiddel.
MX15050A (es) Procedimiento para la preparacion de derivados de 1-arilsulfinil-2-pirrolidinona.
NO912979L (no) Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenederivater.
SE9000948D0 (sv) New use